Use of Retinoids for Psoriasis Treatment

The physician will typically prescribe acitretin at a dosage of 10 to 25 mg per day. The acitretin dosage can be increased up to 50 mg per day, depending on the patient's tolerance, over a period of 3 to 4 months. The treatment should be taken during a meal or with milk to facilitate the absorption of the medication. In case of a missed dose, there are no specific recommendations. If acitretin is combined with a phototherapy, the dosage will generally be maintained at 25 mg per day or less. A maintenance treatment can also be prescribed at a dosage of 25 mg/day.

The treatment of plaque psoriasis, the common form, with acitretin is considered to have moderate effectiveness when used alone. The use of acitretin treatment may be considered when the severity of psoriasis requires a systemic treatment. However, a combination of acitretin and phototherapy in a dermatological cabin allows for an optimal effect in treating the disease. Convincing results are generally observed in about three to four months. Furthermore, acitretin can be administered for the management of less common forms of psoriasis. These include, among others, the pustular psoriasis whether generalized or localized, as well as cases of psoriasis in children.

The primary side effect of acitretin, as with all other retinoids, is skin and mucous membrane dryness. Additionally, at the beginning of treatment, some patients may report hair loss. Headaches, abdominal pain, and muscle pain are also sometimes observed. These symptoms are generally temporary, but if you notice that they persist, do not hesitate to discuss them with your doctor.

Acitretin treatment has been associated in some studies with hepatotoxicity, an increase in intracranial pressure, alterations in glucose tolerance, and photosensitivity. The simultaneous use of retinoids with other therapies having similar side effects may increase the risk of these adverse events.

The decision to take acitretin is based on certain contraindications.

• Pregnancy and breastfeeding.

  For women of childbearing age, it is essential to ensure appropriate contraception. The risks of fetal malformations and the need to continue contraception for three years after stopping treatment must be taken into account. Fetal malformations associated with retinoid treatment include abnormalities of the central nervous system or facial dysmorphia, anomalies of the external ear, etc. Therefore, it is important to discuss with your doctor other therapeutic options if you are considering pregnancy. Breastfeeding is contraindicated during treatment due to the lack of data.

• Drug Interactions.

  One must be cautious of certain drug interactions. The simultaneous use of acitretin and methotrexate is contraindicated as there is a risk of increased hepatotoxicity from methotrexate. Additionally, concurrent use of antibiotics from the tetracycline family can lead to intracranial hypertension. It is also strongly advised against taking other retinoids at the same time as there is an increased risk of hepatotoxicity, elevated intracranial pressure, alterations in glucose tolerance, and photosensitivity.

• The consumption of alcohol.

  A study on volunteer patients using acitretin treatment showed that acitretin combined with alcohol forms etretinate, the previously used retinoid that is highly teratogenic. However, the mechanism of action has not been elucidated.